Evidence map›Paper›PMID 32425996›Full record

SynthesisJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi2021

A systematic review of asymptomatic infections with COVID-19.

Zhiru Gao, Yinghui Xu, Chao Sun, Xu Wang, Ye Guo, Shi Qiu, Kewei Ma

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 480 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
480citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

480 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2023
    Pooled it
  3. Multisystem Inflammatory Syndrome in Adults: Case Finding Through Systematic Review of Electronic Medical Records.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

420 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhiru GaoCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Yinghui XuCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Chao SunCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Xu WangCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Ye GuoCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Shi QiuCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Kewei MaCancer Center, The First Hospital of Jilin University, Changchun, Jilin, 130021, China. Electronic address: makw@jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the outbreak of coronavirus disease 2019 (COVID-19) in late December 2019, it has brought significant harm and challenges to over 200 countries and regions around the world. However, there is increasing evidence that many patients with COVID-19 are asymptomatic or have only mild symptoms, but they are able to transmit the virus to others. There are difficulties in screening for asymptomatic infections, which makes it more difficult for national prevention and control of this epidemic. This article reviews the characteristics, treatment, and outcomes of asymptomatic infections with COVID-19, hoping it would be helpful for early prevention and control of this severe public health threat worldwide.

Indexed as

Asymptomatic InfectionsCOVID-19COVID-19 Nucleic Acid TestingDisease OutbreaksHumansSARS-CoV-2Treatment OutcomeAsymptomatic infectionsCOVID-19Epidemiological characteristicOutcomeSARS-CoV-2

Identifiers

PMID32425996
PMCPMC7227597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.